Indicators

Markets:

News

Latest News about edit

Recent news which mentions edit

< Previous 1 2 3 4 5 6 7 8 9 Next >

After It Fell 15% in 1 Day, Should You Buy The Dip on Editas Stock?

June 20, 2023

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

June 15, 2023

2 Short-Squeeze Candidates That Could Go Parabolic

June 15, 2023

Gambling.com, Editas Medicine And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

June 15, 2023

What 6 Analyst Ratings Have To Say About Editas Medicine

June 13, 2023

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023

June 13, 2023

5 Stocks to Buy With Explosive 500% Potential

June 12, 2023

Editas' Gene Editing Treatment Shows Initial Safety, Efficacy In Patients With Rare Blood Disorders

June 09, 2023

Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today?

June 06, 2023

Genprex (NASDAQ: GNPX) Releases New Patient Video Interview Describing Positive Experience in Clinical Trial

June 01, 2023

7 Short-Squeeze Stocks Set for a May Rally

May 22, 2023

Cathie Wood Is Buying This Biotech Stock Like Wildfire, But Should You?

May 21, 2023

Editas Medicine's Return On Capital Employed Insights

May 19, 2023

ONEOK, PacWest Bancorp And Other Big Stocks Moving Lower In Monday's Pre-Market Session

May 15, 2023

6 Analysts Have This to Say About Editas Medicine

May 08, 2023

Editas Medicine: Q1 Earnings Insights

May 05, 2023

Earnings Scheduled For May 5, 2023

May 05, 2023

Preview: Editas Medicine's Earnings

May 04, 2023

The 3 Most Promising Gene Editing Stocks to Buy in 2023

April 28, 2023

Why Shares of Editas Medicine Rose Monday

April 17, 2023

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session

April 17, 2023

2 Stocks Under $15 Per Share to Consider

April 16, 2023

Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?

April 13, 2023

Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

April 13, 2023

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday

April 13, 2023

Proceed With Caution When Considering These 5 Ultra-Popular Stocks

April 13, 2023

Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio

April 06, 2023

Can This Experimental Gene Therapy Be Enough to Lift Editas Medicine in the Future?

April 03, 2023

2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It

March 30, 2023

7 Biotech Stocks to Buy for Breakthrough Treatments and Cures

March 29, 2023

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.